« Previous
Next »
EJC Supplements
Volume 5, Issue 2
, Pages
32-42
, July 2007
Empirical antifungal therapy in neutropaenic cancer patients with persistent fever
-
Choices of empirical antifungal agents in persistently febrile neutropaenic patients: (a) choice according to the underlying condition; (b) choice according to clinical presentation/condition.
Choices of empirical antifungal agents in persistently febrile neutropaenic patients: (a) choice according to the underlying condition; (b) choice according to clinical presentation/condition.
☆ The ECIL-1 is a common initiative of the following groups or organisations: Infectious Diseases Working Party of the European Blood and Marrow Transplantation Group (EBMT-IDWP), Infectious Diseases Group of the European Organization for Research and Treatment of Cancer (EORTC-IDG), European Leukemia Net (ELN) (EU Grant No.: LSHC-CT-2004), and International Immunocompromised Host Society (ICHS).
PII: S1359-6349(07)00007-9
doi: 10.1016/j.ejcsup.2007.06.005
© 2007 Elsevier Ltd. All rights reserved.
« Previous
Next »
EJC Supplements
Volume 5, Issue 2
, Pages
32-42
, July 2007
